Ingevity (NGVT)
(Delayed Data from NYSE)
$48.51 USD
+0.64 (1.34%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $48.49 -0.02 (-0.04%) 7:58 PM ET
1-Strong Buy of 5 1
B Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/1/24 |
---|---|
Current Quarter | 0.37 |
EPS Last Quarter | 0.21 |
Last EPS Surprise | 261.54% |
ABR | 2.14 |
Earnings ESP
|
39.29% |
---|---|
Current Year | 3.69 |
Next Year | 5.33 |
EPS (TTM) | 3.92 |
P/E (F1) | 12.97 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 319.85M | 424.95M | 1.47B | 1.57B |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 330.60M | 430.90M | 1.53B | 1.67B |
Low Estimate | 309.10M | 419.00M | 1.43B | 1.51B |
Year ago Sales | 392.60M | 481.80M | 1.69B | 1.47B |
Year over Year Growth Est. | -18.53% | -11.80% | -13.25% | 6.89% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.37 | 1.02 | 3.69 | 5.33 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.88 | 1.08 | 3.95 | 6.65 |
Low Estimate | 0.08 | 0.91 | 3.32 | 4.30 |
Year ago EPS | 1.09 | 1.41 | 3.94 | 3.69 |
Year over Year Growth Est. | -66.06% | -27.66% | -6.35% | 44.53% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 1 | 2 | 2 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.37 | 1.02 | 3.69 | 5.33 |
7 Days Ago | 0.12 | 1.07 | 3.66 | 5.15 |
30 Days Ago | 0.07 | 0.75 | 3.65 | 5.14 |
60 Days Ago | 0.10 | 0.84 | 3.80 | 5.28 |
90 Days Ago | 0.11 | 1.23 | 3.82 | 5.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.52 | 1.02 | 3.88 | 5.85 |
Zacks Consensus Estimate | 0.37 | 1.02 | 3.69 | 5.33 |
Earnings ESP | 39.29% | 0.00% | 5.01% | 9.69% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.21 | 1.21 | 1.41 | 1.09 | NA |
Estimate | -0.13 | 1.22 | 1.41 | 1.26 | NA |
Difference | 0.34 | -0.01 | 0.00 | -0.17 | 0.04 |
Surprise | 261.54% | -0.82% | 0.00% | -13.49% | 61.81% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more